Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Despite recent significant advances in genomic techniques, there are currently no practice guidelines for the clinical implementation of genomics.

The Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), in association with researchers at the University of Oxford and the Harvard Stem Cell Institute have today published an Opinion piece in Nature Medicine, which recommends the development of ‘Good Genomic Practice’ (GGP) guidelines. Like good laboratory practice (GLP) and good manufacturing practice (GMP), GGP aims to ‘ensure the quality and consistency of medical research and practice’ in the field.

The proposed guidelines would address the ethical, scientific, quality assurance, data handling and storage issues surrounding genomic diagnosis, setting out best practice principles from ‘initial sample collection to the ultimate clinical decision.

Good practice guidelines in this field would result in greater consistency in the reported results as well as an improved understanding of the clinical significance of genetic variants. Not only is this a step towards stratifying medicine; but also the development of integrated global databases with standardized formats, bringing the ultimate goal of truly personalizing treatments closer.

The authors suggest that international leaders in the genomics field should create a checklist to map out the key stages in the process that require standardization and then work with wider stakeholders to formulate guidelines.  Defining the parameters of GGP at this early stage will ensure that the field realizes its ‘boundless potential to improve human health.’


Links:

Original paper in Nature

CASMI

Similar stories

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.

New study shows higher rate of fractures in people with intellectual disability

In the most comprehensive study of its kind, researchers at the University of Oxford and Oxford Health NHS Foundation Trust found a substantially higher rate of fractures in people with intellectual disability compared with people of the same age and gender without an intellectual disability.

New evidence for how our brains handle surprise

A new study from the Bruno Group is challenging our perceptions of how the different regions of the cerebral cortex function. A group of ‘quiet’ cells in the somatosensory cortex that rarely respond to touch have been found to react mainly to surprising circumstances. The results suggest their function is not necessarily driven by touch, but may indicate an important and previously unidentified role across all the major cortices.

Language learning difficulties in children linked to brain differences

A new study using MRI has revealed structural brain changes in children with developmental language disorder (DLD), a common but under-recognised difficulty in language learning. Children with DLD aged 10-15 showed reduced levels of myelin in areas of the brain associated with speaking and listening to others, and areas involved in learning new skills. This finding is a significant advance in our understanding of DLD and these brain differences may explain the poorer language outcomes in this group.

New research reveals relationship between particular brain circuits and different aspects of mental wellbeing

Researchers at the University of Oxford have uncovered previously unknown details about how changes in the brain contribute to changes in wellbeing.